Save up -80% on Vilanterol

Note: this is a drug discount program, not an insurance plan.
RX BIN: 015558RX PCN: HTGroup ID: DDN6600Card Holder ID: DDN6600
Pharmacists and Patients support.

2019 Price of Anoro Ellipta

$423.091 inhaler (60 blisters) 62.5mcg/25mcg
price without discount in nearest pharmacy. Price may vary.

Claim your free Vilanterol discount card

We offer free Anoro Ellipta coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your manufacturer copay card in most local pharmacies to get a discount on Vilanterol every time. What are you waiting for? Claim your prescription drug card now!

Walgreens pharmacy
Walgreens pharmacy
CVS pharmacy
CVS pharmacy
Walmart pharmacy
Walmart pharmacy
Ride AID pharmacy
Ride AID pharmacy
CVS Target pharmacy
CVS Target pharmacy
Kroger pharmacy
Kroger pharmacy
rx

Get your Prescription

safe

It’s safe and free

pharmacy

Buy drugs in pharmacy

save money

Save money each time

Vilanterol volume of distribution

Following IV administration to healthy subjects, the mean volume of distribution at steady state was 661 L. Following repeat dosing of inhaled vilanterol, steady state was achieved within 6 days with up to 2.4-fold accumulation. Following intravenous administration to healthy subjects, the mean volume of distribution was 86 litres. In vitro plasma protein binding in human plasma was on average 89%.

RX Prescription
Ask Your therapeut before taking any drugs.

About RX24Drugs

2018 Statistics

discount card

Discount Cards 16,000+

benefit

Clients Benefit 29%

savings

Total savings $4,735,080

What is Vilanterol

Vilanterol is a selective long-acting beta2-adrenergic agonist (LABA) with inherent 24-hour activity for once daily treatment of COPD and asthma. Its pharmacological effect is attributable to stimulation of intracellular adenylyl cyclase which catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3′,5′-adenosine monophosphate (cAMP). Increases in cyclic AMP are associated with relaxation of bronchial smooth muscle and inhibition of release of hypersensitivity mediators from mast cells in the lungs. Vilanterol is approved for use in several combination products such as with fluticasone furoate under the tradename Breo Ellipta and in combination with umeclidinium bromide as Anoro Ellipta. Approved by the FDA in 2013, use of Breo Ellipta is indicated for the long-term, once-daily maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and emphysema. It is also indicated for once-daily maintenance treatment of asthma in patients aged 18 or older with reversible obstructive airways disease.

Vilanterol mechanism of action

Vilanterol is a selective long-acting beta2-adrenergic agonist. Its pharmacological effect is attributable to stimulation of intracellular adenylyl cyclase which catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3′,5′-adenosine monophosphate (cAMP). Increases in cyclic AMP are associated with relaxation of bronchial smooth muscle and inhibition of release of hypersensitivity mediators from mast cells in the lungs.

Dosage forms of Vilanterol

DrugDosageQuantityPrice
Anoro Ellipta22mcg30doses Dry Powder Inhaler$120.00
Anoro Ellipta22mcg90doses Dry Powder Inhaler$346.00
Breo Ellipta22mcg30doses Powder Inhaler$147.00
Breo Ellipta22mcg90doses Powder Inhaler$420.00
Trelegy Ellipta22mcg30 doses Inhalation Powder$133.00
Trelegy Ellipta22mcg90 doses Inhalation Powder$366.00

Prescription Generics

false

International Brands

Anoro Ellipta

Synonyms

4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol vilanterol

Manufacturers

Glaxosmithkline Inc

CAS number

503068-34-6

UNII

028LZY775B

State

solid

Affected organisms

Indication of Vilanterol

Vilanterol is approved for use in several combination products such as with fluticasone furoate under the tradename Breo Ellipta and in combination with umeclidinium bromide as Anoro Ellipta. Approved by the FDA in 2013, use of Breo Ellipta is indicated for the long-term, once-daily maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and emphysema. It is also indicated for once-daily maintenance treatment of asthma in patients aged 18 or older with reversible obstructive airways disease.

Toxicity of Vilanterol

Anoro Ellipta is NOT approved for use in asthma. Anoro Ellipta can cause serious side effects, including: People with asthma who take long-acting beta2-adrenergic agonist (LABA) medicines, such as vilanterol (one of the medicines in Anoro Ellipta), have an increased risk of death from asthma problems.

RX24 Drugs Disclaimer: consult your healthcare provider before buying a Vilanterol on prescription or using an RX manufacturer savings coupon. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.

Get lower price on Vilanterol now!

What is a Anoro Ellipta?

Anoro Ellipta is an inhalable powder containing a combination of umeclidine and Vilanterol. Umeclidinium is anticholinergic. Vilanterol is a bronchodilator. These medicines work by relaxing the muscles in the airways to improve breathing. Anoro Ellipta is used to prevent airflow obstruction or bronchospasm in people with COPD (chronic obstructive pulmonary disease).

Anoro Ellipta can also be used for purposes not listed in this manual. Anoro Ellipta is intended only for people with chronic obstructive pulmonary disease (COPD) and should not be used to treat asthma. Vilanterol may increase the risk of death in people with asthma, but the risk in people with COPD is unknown. Seek medical attention if your breathing problems do not improve, or if your symptoms worsen quickly.

Anoro Ellipta will not work fast enough to treat bronchospasm. Use only a fast-acting inhalant to attack.